-
srdr.ahrq.gov/projects/1671/studies/196172
January 01, 1999 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196185
January 01, 1991 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196154
January 01, 2010 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196145
January 01, 2011 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196162
January 01, 1996 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196175
January 01, 2015 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196184
January 01, 1991 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196178
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196150
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196157
January 01, 1992 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196173
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196186
medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196166
January 01, 2018 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196169
January 01, 1998 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196156
January 01, 2008 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196165
January 01, 2017 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196148
January 01, 2001 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196393
January 01, 2005 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196198
January 01, 2003 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?
-
srdr.ahrq.gov/projects/1671/studies/196188
January 01, 2004 - medications, and cannabis) versus: 1) other nonopioid pharmacologic treatments, such as those in a different medication … demographics (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) duration of treatment? … patient demographics (e.g. age, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … ; (4) dose of medication; (5) the duration of therapy?